Prominent

Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes
Contact phone
Sparrow Clinical Research Institute 517-364-5760
Principal investigator
Dr. David Strobl, DO
Trial Category
Heart & Vascular
Trial SubCategory
Lipid Management